New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Banned News and commentary from the endocrinology world Jul 09, 2024
Tirzepatide Bests Semaglutide for Real-World Weight Loss Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers For people with diabetes, cancer risks were reduced with GLP-1s versus insulin Jul 05, 2024
More Data Link Obesity to Better Survival for Cancer Patients on Immunotherapy Higher BMI also associated with improvements in functional outcomes in this setting Jul 04, 2024
Semaglutide May Be Linked to Condition That Causes Blindness Association with optic neuropathy in observational data needs further study to assess causality Jul 03, 2024
House Panel OKs Bills on Obesity Drug and Breakthrough Device Coverage in Medicare Meanwhile, CMS proposed rule on the device coverage, issued a year ago, awaits a final version Jul 01, 2024
CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabetics News and commentary from the endocrinology world Jul 01, 2024
Many Kids Benefit From GLP-1s. What Happens When They Have to Stop Taking Them? Prepare patients early for a time when medication is no longer an option Jul 01, 2024
Adolescent Obesity Tied to Parents' BMI at the Same Age Moderate association between parental and offspring BMI at age 17 Jun 28, 2024
First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warning News and commentary from the endocrinology world Jun 25, 2024
Major Heart Events Down With Metabolic Surgery for Apnea Patients With Obesity All-cause mortality also lower compared with nonsurgical controls Jun 24, 2024
Novel GLP-1/Glucagon Drug Promising for Weight Loss Phase II data support testing pemvidutide for comorbid obesity and liver conditions Jun 24, 2024
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D Insulin sensitivity also improved in people with obesity free of diabetes Jun 23, 2024
Tirzepatide May Help Treat Sleep Apnea in People With Obesity Zepbound met primary and secondary endpoints, with or without CPAP Jun 21, 2024
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis Previous exposure to biologics, higher BMI, smoking all negatively linked to response Jun 18, 2024
Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss News and commentary from the endocrinology world Jun 18, 2024
USPSTF Recommends Behavioral Interventions for Kids With High BMI Final recommendations did not include weight-loss drugs Jun 18, 2024
For Teens With Severe Obesity, Financial Incentives Work for Weight Loss Randomized trial proves benefit of adding gift card incentives to dietary measures Jun 17, 2024
Two OTC CGMs Cleared; USPSTF Draft Recs for Osteoporosis; Generic Ozempic in Testing News and commentary from the endocrinology world Jun 11, 2024
Missing Doc Found Dead; Trump's False Insulin Claim; CDC's Bird Flu Study Health news and commentary gathered by 鶹ý staff Jun 10, 2024
Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ... Analysis of patients with obesity and diabetes only looked at first-generation GLP-1 agonists Jun 07, 2024
Search for Missing Doctor; Energy Drinks and Sudden Death; Unusual Pandemic Cancers Health news and commentary gathered by 鶹ý staff Jun 07, 2024
ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risks More research from the Endocrine Society's annual meeting Jun 05, 2024
Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Tx News and commentary from the endocrinology world Jun 03, 2024
Semaglutide May Boost Taste Sensitivity Other taste-related changes also potentially seen with the GLP-1 agent in proof-of-concept study Jun 02, 2024
Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24 Percentage weight loss is in line with pivotal trial results using standard obesity thresholds May 31, 2024
How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use? News and commentary from the endocrinology world May 28, 2024
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Options "I'm having to jump through hoops to live," says one patient May 26, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
Nutrition Experts Call on Congress to Advance 'Food Is Medicine' Movement Produce prescriptions, medically tailored meals improve quality of life, cut costs, they say May 22, 2024
GLP-1 Agonist Scripts Jumped 600% for Teens, Young Adults Since 2020 Females accounted for most of the prescription fills May 22, 2024
Insufficient Sleep May Influence Cognition in Teens With Overweight and Obesity Restricted sleep did not have same effects on adolescents with less weight May 21, 2024
Endoscopic Ablation Reduces 'Hunger Hormone,' Yields Weight Loss in Early Trial First-in-human study targets ghrelin production with mucosal ablation as obesity treatment May 21, 2024
South Park Takes on Wegovy; Decapitated Doc's Killer Sentenced; Deadliest Superbugs Health news and commentary gathered by 鶹ý staff May 17, 2024
Obesity Mystery Solved: The Reversible Cause You Never Knew Can you guess what caused this patient's extreme weight gain? May 16, 2024
Smartphone-Based Lifestyle Interventions Result in Modest, Sustained Weight Loss Interventions important for patients with no access to medical or surgical treatments May 15, 2024
Obesity, Low Body Mass Linked to Mental Health Concerns in Adolescents Psychosomatic concerns also increased significantly from 2002 to 2018 May 15, 2024
Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines News and commentary from the endocrinology world May 14, 2024
Slow Responders to Zepbound Achieve Meaningful Weight Loss Eventually It can take 20 weeks to titrate to highest dose, researcher points out May 10, 2024
